Revelation Pharma Appoints Nancy Fingerhut as Vice President of Quality Assurance and Regulatory Affairs

Industry Veteran Nancy Fingerhut to Lead Regulatory and Quality Excellence Across Revelation Pharma's Nationwide Network

ATLANTA, Feb. 12, 2025 /PRNewswire/ -- Revelation Pharma, a leading nationwide network of 503A and 503B compounding pharmacies, has promoted regulatory expert Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs. In this elevated role, Fingerhut will drive regulatory excellence across Revelation Pharma's growing network, ensuring the highest industry standards in patient safety and compliance.

Fingerhut joined Revelation Pharma through its acquisition of Lee Silsby Compounding Pharmacy, where she served as Chief Operating Officer. With more than 20 years of experience in regulatory compliance, she has built a reputation for setting the gold standard in quality assurance. Having overseen all facets of a compounding pharmacy's regulatory and quality assurance programs, she is uniquely equipped to ensure strict adherence to state and federal regulatory compliance across all of Revelation Pharma's facilities.

"At Revelation, I have the privilege of working with leaders who demonstrate a profound dedication to regulatory excellence." said Nancy, "It's for this reason that our mission will be served – an unwavering commitment to quality for our patients."

Fingerhut's passion for upholding impeccable ethics and her commitment to patient safety have been the cornerstones of her career. As Vice President of Quality Assurance and Regulatory Affairs, she will spearhead initiatives to uphold and strengthen the ambitious standards Revelation Pharma maintains as it continues its strategic expansion of "buying and building" reputable compounding pharmacies.

"We couldn't be more excited to have Nancy step into this new role," said Shawn Hodges, CEO of Revelation Pharma. "Her extensive regulatory expertise and unwavering dedication to quality make her the ideal leader to guide our entire national network. With Nancy at the helm, Revelation Pharma will continue to set the standard of excellence for regulatory responsibility.

About Revelation Pharma 

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative, quality, and personalized pharmaceutical preparations and services through "industry best" patient care. With a footprint in all 50 states and virtual telemedicine, Revelation Pharma can serve patients and healthcare providers nationwide. Revelation Pharma's therapeutic scope spans several areas of medicine including Women's Health, Men's Health, Dermatology and Cosmeceuticals, Anti-Infective, IV/IM Nutrition, Weight Management, Animal Health, Ophthalmic/Eye Care, Allergy/Immunotherapy and Functional Medicine. 

Revelation Pharma's businesses include Revelation Wholesale, Penile Rehab Protocol Revelation Animal Health, ConsultRx, Pharmacist Formulations, and Eagle Pharma Outsourcing.

To learn more, visit our website, and follow us on Facebook, YouTube, LinkedIn and Instagram.

Media Contact:
Chelsea Kershaw
909-573-7237
390091@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/revelation-pharma-appoints-nancy-fingerhut-as-vice-president-of-quality-assurance-and-regulatory-affairs-302374360.html

SOURCE Revelation Pharma